Literature DB >> 21185349

Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.

Agnieszka Dejda1, Steve Bourgault, Ngoc Duc Doan, Myriam Létourneau, Alain Couvineau, Hubert Vaudry, David Vaudry, Alain Fournier.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) exerts many crucial biological functions through the interaction with its specific PAC1 receptor (PAC1-R), a class B G protein-coupled receptor (GPCR). To identify the binding sites of PACAP in the PAC1-R, three peptide derivatives containing a photoreactive p-benzoyl-phenylalanine (Bpa) residue were developed. These photosensitive PACAP analogs were fully biologically active and competent to displace radiolabeled Ac-PACAP27 from the PAC1-R. Subsequently, the (125)I-labeled photoprobes were used to anchor the PAC1-R expressed in Chinese hamster ovary cells. Photolabeling led to the formation of two protein complexes of 76 and 67 kDa, representing different glycosylated forms of the receptor. Proteinase and chemical cleavages of the peptide-receptor complexes revealed that (125)I[Bpa(0), Nle(17)]PACAP27, (125)I[Bpa(6), Nle(17)]PACAP27 and (125)I[Nle(17), Bpa(22)]PACAP27 covalently labeled the Ser(98) - Met(111) segment, the Ser(124) - Glu(125) dipeptide and the Ser(141) - Met(172) fragment, respectively. Taking into account the topology of the PAC1-R, these segments are mainly located within the extracellular N-terminal domain, indicating that this PAC1-R domain is the major binding site of PACAP27. The present study constitutes the first characterization of the binding domains of PACAP to its specific receptor and suggests heterogeneity within the binding mode of peptide ligands to class B GPCRs.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185349     DOI: 10.1016/j.biochi.2010.12.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  10 in total

Review 1.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Functional Pairing of Class B1 Ligand-GPCR in Cephalochordate Provides Evidence of the Origin of PTH and PACAP/Glucagon Receptor Family.

Authors:  Jason S W On; Cumming Duan; Billy K C Chow; Leo T O Lee
Journal:  Mol Biol Evol       Date:  2015-04-03       Impact factor: 16.240

3.  Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models.

Authors:  Philip Lazarovici; Gadi Cohen; Hadar Arien-Zakay; Jieli Chen; Chunling Zhang; Michael Chopp; Hao Jiang
Journal:  J Mol Neurosci       Date:  2012-06-08       Impact factor: 3.444

Review 4.  Advent and recent advances in research on the role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of gonadotropic hormone secretion of female rats.

Authors:  Katalin Köves; Orsolya Kántor; András Lakatos; Enikő Szabó; Eszter Kirilly; Andrea Heinzlmann; Flóra Szabó
Journal:  J Mol Neurosci       Date:  2014-04-03       Impact factor: 3.444

5.  Pituitary Adenylate Cyclase-Activating Polypeptide Protects Against Cognitive Impairment Caused by Chronic Cerebral Hypoperfusion.

Authors:  Xiaosu Guo; Ye Tian; Yaping Yang; Shiping Li; Li Guo; Jiong Shi
Journal:  Mol Neurobiol       Date:  2021-05-17       Impact factor: 5.590

Review 6.  Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.

Authors:  Yossan-Var Tan; James A Waschek
Journal:  ASN Neuro       Date:  2011-10-06       Impact factor: 4.146

7.  Investigation of PACAP Fragments and Related Peptides in Chronic Retinal Hypoperfusion.

Authors:  Dora Werling; Dora Reglodi; Peter Kiss; Gabor Toth; Krisztina Szabadfi; Andrea Tamas; Zsolt Biro; Tamas Atlasz
Journal:  J Ophthalmol       Date:  2014-05-12       Impact factor: 1.909

Review 8.  Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin.

Authors:  Robert Gábriel; Etelka Pöstyéni; Viktória Dénes
Journal:  Front Neurosci       Date:  2019-10-09       Impact factor: 4.677

9.  PACAP/GCGa Is an Important Modulator of the Amphioxus CNS-Hatschek's Pit Axis, the Homolog of the Vertebrate Hypothalamic-Pituitary Axis in the Basal Chordates.

Authors:  Jason S W On; Liuru Su; Hong Shen; Aloysius W R Arokiaraj; João C R Cardoso; Guang Li; Billy K C Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

Review 10.  Current State of Understanding of the Role of PACAP in the Hypothalamo-Hypophyseal Gonadotropin Functions of Mammals.

Authors:  Katalin Köves; Enikő Szabó; Orsolya Kántor; Andrea Heinzlmann; Flóra Szabó; Ágnes Csáki
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.